Mijke Buitinga

945 total citations
37 papers, 647 citations indexed

About

Mijke Buitinga is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mijke Buitinga has authored 37 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 12 papers in Genetics and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mijke Buitinga's work include Pancreatic function and diabetes (16 papers), Diabetes and associated disorders (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). Mijke Buitinga is often cited by papers focused on Pancreatic function and diabetes (16 papers), Diabetes and associated disorders (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). Mijke Buitinga collaborates with scholars based in Netherlands, Belgium and Switzerland. Mijke Buitinga's co-authors include Martin Gotthardt, Maarten Brom, Marti Boss, Chantal Mathieu, Lut Overbergh, Eelco J.P. de Koning, Aart A. van Apeldoorn, Marcel Karperien, Marten A. Engelse and Clemens van Blitterswijk and has published in prestigious journals such as Nature Communications, PLoS ONE and Biomaterials.

In The Last Decade

Mijke Buitinga

35 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mijke Buitinga Netherlands 15 265 155 149 138 131 37 647
Hirotake Komatsu United States 14 472 1.8× 193 1.2× 154 1.0× 194 1.4× 145 1.1× 48 735
Daniela Kodetová Czechia 12 130 0.5× 361 2.3× 256 1.7× 186 1.3× 133 1.0× 35 779
Yasutaka Kato Japan 15 148 0.6× 31 0.2× 356 2.4× 229 1.7× 59 0.5× 45 846
Natalie Seiser United States 9 187 0.7× 94 0.6× 189 1.3× 129 0.9× 22 0.2× 11 578
Fadime Dogan Netherlands 13 126 0.5× 194 1.3× 128 0.9× 259 1.9× 18 0.1× 29 614
Robin Buerki United States 11 102 0.4× 65 0.4× 225 1.5× 166 1.2× 28 0.2× 25 754
Jatuporn Sujjitjoon Thailand 16 214 0.8× 38 0.2× 145 1.0× 310 2.2× 111 0.8× 30 508
Antonio Citro Italy 16 499 1.9× 185 1.2× 238 1.6× 181 1.3× 281 2.1× 41 950
Udo Siebolts Germany 16 108 0.4× 61 0.4× 289 1.9× 208 1.5× 30 0.2× 61 797
Imran S. Khan United States 12 79 0.3× 164 1.1× 315 2.1× 171 1.2× 84 0.6× 16 868

Countries citing papers authored by Mijke Buitinga

Since Specialization
Citations

This map shows the geographic impact of Mijke Buitinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mijke Buitinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mijke Buitinga more than expected).

Fields of papers citing papers by Mijke Buitinga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mijke Buitinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mijke Buitinga. The network helps show where Mijke Buitinga may publish in the future.

Co-authorship network of co-authors of Mijke Buitinga

This figure shows the co-authorship network connecting the top 25 collaborators of Mijke Buitinga. A scholar is included among the top collaborators of Mijke Buitinga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mijke Buitinga. Mijke Buitinga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinhanços, Sandra S., Joana Oliveira, C. Henrique Alves, et al.. (2025). miRNA-642a-3p protects β cells from glucolipotoxicity. Molecular Therapy — Nucleic Acids. 36(2). 102498–102498.
2.
Buitinga, Mijke, Sanne A. M. van Lith, Lieke Joosten, et al.. (2024). Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas. EJNMMI Research. 14(1). 96–96.
3.
Mevenkamp, Julian, Yvonne M. H. Bruls, Lotte Grevendonk, et al.. (2024). Development of a 31P magnetic resonance spectroscopy technique to quantify NADH and NAD+ at 3 T. Nature Communications. 15(1). 9159–9159. 4 indexed citations
4.
Buitinga, Mijke, et al.. (2023). Ectopic lipid deposition in muscle and liver, quantified by proton magnetic resonance spectroscopy. Obesity. 31(10). 2447–2459. 3 indexed citations
5.
Boss, Marti, Olle Eriksson, Annemarie Eek, et al.. (2023). Improved localization of insulinomas using 68Ga-NODAGA-exendin-4 PET/CT. Nuklearmedizin - NuclearMedicine. 62(2). 97–98. 4 indexed citations
6.
Eelen, Guy, Rita Derua, Mijke Buitinga, et al.. (2023). NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic Proteins. Cells. 12(9). 1319–1319. 5 indexed citations
7.
Frenken, Koen, Johanna A. Jörgensen, Esther Moonen‐Kornips, et al.. (2023). Exercise training modifies skeletal muscle clock gene expression but not 24‐hour rhythmicity in substrate metabolism of men with insulin resistance. The Journal of Physiology. 602(23). 6417–6433. 10 indexed citations
8.
Buitinga, Mijke, Hannelie Korf, Kristina Casteels, et al.. (2023). High-Throughput Analysis of Neutrophil Extracellular Trap Levels in Subtypes of People with Type 1 Diabetes. Biology. 12(6). 882–882. 3 indexed citations
9.
Brom, Maarten, Marti Boss, Mijke Buitinga, et al.. (2022). Importance of beta cell mass for glycaemic control in people with type 1 diabetes. Diabetologia. 66(2). 367–375. 5 indexed citations
10.
Buitinga, Mijke, et al.. (2021). Targeting citrullination in autoimmunity: insights learned from preclinical mouse models. Expert Opinion on Therapeutic Targets. 25(4). 269–281. 13 indexed citations
11.
Boss, Marti, Christof Rottenburger, Winfried Brenner, et al.. (2021). 68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism. Journal of Nuclear Medicine. 63(2). 310–315. 18 indexed citations
12.
Tilvawala, Ronak, Dana P. Cook, Claire Berthault, et al.. (2020). Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice. Diabetes. 70(2). 516–528. 33 indexed citations
13.
Boss, Marti, Desirée L. Bos, Cathelijne Frielink, et al.. (2020). Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions. Journal of Nuclear Medicine. 61(11). 1588–1593. 14 indexed citations
14.
Boss, Marti, et al.. (2019). PET-Based Human Dosimetry of 68Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging. Journal of Nuclear Medicine. 61(1). 112–116. 27 indexed citations
15.
Buitinga, Mijke, Inne Crèvecoeur, Meiling Yang, et al.. (2018). Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 Diabetes. Diabetes. 67(11). 2337–2348. 60 indexed citations
16.
Buitinga, Mijke, Marti Boss, Marcel Janssen, et al.. (2018). Succinylated Gelatin Improves the Theranostic Potential of Radiolabeled Exendin-4 in Insulinoma Patients. Journal of Nuclear Medicine. 60(6). 812–816. 23 indexed citations
17.
Buitinga, Mijke, Frank P. Assen, Paul Wieringa, et al.. (2017). Micro-fabricated scaffolds lead to efficient remission of diabetes in mice. Biomaterials. 135. 10–22. 32 indexed citations
18.
Andralojc, Karolina M., Mijke Buitinga, Cathelijne Frielink, et al.. (2017). Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3. Scientific Reports. 7(1). 7232–7232. 18 indexed citations
19.
Buitinga, Mijke, Jacqueline Plass, Françoise Carlotti, et al.. (2016). Coculturing Human Islets with Proangiogenic Support Cells to Improve Islet Revascularization at the Subcutaneous Transplantation Site. Tissue Engineering Part A. 22(3-4). 375–385. 23 indexed citations
20.
Buitinga, Mijke, Eelco J.P. de Koning, Roman Truckenmüller, et al.. (2011). Microwell scaffolds for extrahepatic islet of Langerhans transplantation in type 1 diabetes. The International Journal of Artificial Organs. 34(8). 632–633. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirotake Komatsu Breakdown of academic impact, for papers by Daniela Kodetová Breakdown of academic impact, for papers by Yasutaka Kato Breakdown of academic impact, for papers by Natalie Seiser Breakdown of academic impact, for papers by Fadime Dogan Breakdown of academic impact, for papers by Robin Buerki Breakdown of academic impact, for papers by Jatuporn Sujjitjoon Breakdown of academic impact, for papers by Antonio Citro Breakdown of academic impact, for papers by Udo Siebolts Breakdown of academic impact, for papers by Imran S. Khan
Rankless by CCL
2026